Medicinova Free Cash Flow (FCF) History (MNOV)
Medicinova reported −$9.8M in free cash flow for fiscal 2025, an increase of $830,899 from the previous fiscal year, with a free cash flow margin of −2395.41%.
View full Medicinova company overviewMedicinova free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$9.8M | $830,899 | — | −2395.41% |
| 2024 | 2024-12-31 | −$10.6M | −$3.2M | — | — |
| 2023 | 2023-12-31 | −$7.5M | $5.5M | — | −745.23% |
| 2022 | 2022-12-31 | −$12.9M | −$3.5M | — | — |
| 2021 | 2021-12-31 | −$9.4M | $1.5M | — | −233.07% |
| 2020 | 2020-12-31 | −$10.9M | −$1.7M | — | — |
| 2019 | 2019-12-31 | −$9.1M | −$11,938 | — | — |
| 2018 | 2018-12-31 | −$9.1M | −$2.5M | — | — |
| 2016 | 2016-12-31 | −$6.6M | $523,994 | — | — |
| 2015 | 2015-12-31 | −$7.2M | −$8.0M | — | — |
| 2014 | 2014-12-31 | $813,006 | $11.5M | — | — |
| 2013 | 2013-12-31 | −$10.7M | $1.3M | — | — |
| 2012 | 2012-12-31 | −$11.9M | $1.4M | — | −1488.68% |
| 2011 | 2011-12-31 | −$13.3M | $4.4M | — | — |
| 2010 | 2010-12-31 | −$17.7M | −$686,029 | — | — |
| 2009 | 2009-12-31 | −$17.0M | — | — | — |
Medicinova quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$1.9M | $386,357 | — | −418.82% |
| Q1 2026 | 2026-03-31 | −$3.5M | $302,623 | — | −1861.68% |
| Q4 2025 | 2025-12-31 | −$2.0M | $15,263 | — | — |
| Q3 2025 | 2025-09-30 | −$1.7M | −$331,803 | — | −1383.48% |
| Q2 2025 | 2025-06-30 | −$2.3M | $712,155 | — | −1713.54% |
| Q1 2025 | 2025-03-31 | −$3.8M | −$1.8M | — | — |
| Q3 2024 | 2024-09-30 | −$2.0M | $1.9M | — | — |
| Q3 2023 | 2023-09-30 | −$1.4M | $716,274 | — | −137.43% |
| Q3 2021 | 2021-09-30 | −$3.0M | −$137,345 | — | −8049.50% |
| Q4 2020 | 2020-12-31 | −$2.0M | $429,858 | — | — |
| Q3 2020 | 2020-09-30 | −$3.9M | −$1.9M | — | — |
| Q2 2020 | 2020-06-30 | −$2.1M | −$436,197 | — | — |
| Q1 2020 | 2020-03-31 | −$2.9M | $150,027 | — | — |
| Q4 2019 | 2019-12-31 | −$2.4M | −$767,871 | — | — |
| Q3 2019 | 2019-09-30 | −$2.0M | −$303,408 | — | — |
| Q2 2019 | 2019-06-30 | −$1.7M | $619 | — | — |
| Q1 2019 | 2019-03-31 | −$3.0M | $1.1M | — | — |
| Q4 2018 | 2018-12-31 | −$1.6M | −$567,537 | — | — |
| Q3 2018 | 2018-09-30 | −$1.7M | −$119,358 | — | — |
| Q2 2018 | 2018-06-30 | −$1.7M | −$158,136 | — | — |
| Q1 2018 | 2018-03-31 | −$4.1M | −$1.6M | — | — |
| Q4 2016 | 2016-12-31 | −$1.1M | −$43,463 | — | — |
| Q3 2016 | 2016-09-30 | −$1.6M | −$25,244 | — | — |
| Q2 2016 | 2016-06-30 | −$1.5M | −$168,727 | — | — |
| Q1 2016 | 2016-03-31 | −$2.4M | −$7.2M | — | — |
| Q4 2014 | 2014-12-31 | −$1.0M | $888,154 | — | — |
| Q3 2014 | 2014-09-30 | −$1.6M | $595,837 | — | — |
| Q2 2014 | 2014-06-30 | −$1.3M | $1.1M | — | — |
| Q1 2014 | 2014-03-31 | $4.8M | $8.6M | — | — |
| Q3 2013 | 2013-09-30 | −$1.9M | $1.5M | — | — |
| Q4 2012 | 2012-12-31 | −$2.2M | $793,147 | — | −6432.62% |
| Q3 2012 | 2012-09-30 | −$2.4M | $1.4M | — | −2913.07% |
| Q2 2012 | 2012-06-30 | −$3.9M | — | — | −787.05% |
| Q1 2012 | 2012-03-31 | −$3.4M | — | — | −1796.88% |
| Q3 2011 | 2011-09-30 | −$3.0M | — | — | — |
| Q3 2010 | 2010-09-30 | −$3.8M | — | — | — |
Medicinova free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$10.9M to −$9.8M, a net increase of $1.0M. Medicinova's latest reported quarter, Q2 2026, generated −$1.9M in free cash flow, an increase of $386,357 year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Medicinova filings at SEC.gov ↗